Therapy for Advanced Atherosclerosis by Using Vascular Endocrinological System

血管内分泌系统治疗晚期动脉粥样硬化

基本信息

  • 批准号:
    11670672
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

We tried to use vascular endocrinological system (citrulline-arginine cycle) for therapy of advanced atherosclerosis. We also tried to investigate the role of inducible nitric oxide synthase (iNOS) and soluble guanylate cyclase in aged advanced atherosclerotic animal model. Firstly, we observed iNOS and ONOO^- in T cell and macrophages in rabbit advanced atherosclerosis. Application of L-arginine but not citrulline retards progression of atherosclerosis. Secondly, we determined dothelial and non-endothelial vascular responses, eNOS and soluble guanylate cyclase (sGC) using rats model. Hyperglycemia was induced by intraperitoneal injection of streptozotocin in young (9wks), middle aged (54wks) and elderly (108 wks) male wister rats. After 1 to 12 weeks of hyperglycemia induction, rats were sacrificed and NO related responses and molecular analyses were investigated in thoracic aortas. The fasting blood glucose was increased 340±13 mg/dl in hyperglycemic induced rats. NO stimulated and basal responses were not significantly changed in younger (9wks.) rats when they were slightly decreased under hyperglycemia for more than 9 weeks. Endothelium independent response by nitroglycerin was diminished in elderly rats (108 wks) as compared with those in younger and middle aged rats (54 wks). Further, it was diminished in status of hyperglycemia for longer than 4 weeks. NO stimulated and basal responses were slightly decreased in aortas of elderly rats, and significantly decreased in hyperglycemia and depending on the duration of hyperglycemia. eNOS and soluble guanylate cyclase protein tended to decrease in aged diabetic rats. Further, O_2^- was increased by aging and hyperglycemia.
我们试图利用血管内分泌系统(瓜氨酸-精氨酸循环)治疗晚期动脉粥样硬化。本研究还探讨了诱导型一氧化氮合酶(iNOS)和可溶性鸟苷酸环化酶在老年晚期动脉粥样硬化动物模型中的作用。首先,我们观察了家兔动脉粥样硬化晚期T细胞和巨噬细胞中iNOS和ONOO^-的表达。应用L-精氨酸而不是瓜氨酸可延缓动脉粥样硬化的进展。第二,采用大鼠模型,测定内皮和非内皮血管反应、eNOS和可溶性鸟苷酸环化酶(sGC)。用链脲佐菌素(STZ)腹腔注射法建立青年(9周龄)、中年(54周龄)和老年(108周龄)雄性Wister大鼠高血压模型。在高血糖诱导1至12周后,处死大鼠,并在胸部动脉瘤中研究NO相关反应和分子分析。高血糖大鼠空腹血糖升高340±13 mg/dl。NO刺激和基础反应在年轻(9周)没有显着变化。大鼠在高血糖状态下持续9周以上,与中青年大鼠(54周)相比,老年大鼠(108周)对硝酸甘油的内皮非依赖性反应减弱。此外,高血糖状态持续时间超过4周。NO刺激反应和基础反应在老年大鼠睾丸中略有降低,在高血糖时显著降低,并依赖于高血糖的持续时间。eNOS和可溶性鸟苷酸环化酶蛋白在老年糖尿病大鼠有下降趋势。衰老和高血糖使O_2^-增加。

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hayashi T, Esaki T, Muto E, Sumi D, Kano H, Thakur NK, Iguchi A: "Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia -The possible role of peroxynitrite-."Atherosclerosis. 147. 349-367 (1999)
Hayashi T、Esaki T、Muto E、Sumi D、Kano H、Thakur NK、Iguchi A:“通过控制高脂血症并不能恢复兔动脉粥样硬化主动脉的内皮依赖性松弛 - 过氧亚硝酸盐的可能作用 - 。”动脉粥样硬化。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Watanabe H, Fukao M, Liu M, Hayashi T, Iguchi A, Ohashi K: "Myosin light chain kinase regulates endothelial calcium entry and endothelium-dependent vasodilatation"FASEB J. (in press). (2001)
Watanabe H、Fukao M、Liu M、Hayashi T、Iguchi A、Ohashi K:“肌球蛋白轻链激酶调节内皮钙进入和内皮依赖性血管舒张”FASEB J.(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
林登志雄,井口昭久,: "総説)血管壁への直接作用を介した動脈硬化症治療-動脈硬化退縮療法におけるNOの役割-(分担執筆分)"血管. 45-53 (2000)
Toshio Hayashi,Akihisa Iguchi,:“评论)通过直接作用于血管壁的动脉硬化治疗 - NO 在动脉硬化消退治疗中的作用 -(贡献者)”Vaskan 45-53 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hayashi T,Iguchi A.: "NIPRADILOL:The βadrenoreceptorantagonist with NOreleasing capacity."Cardiovasc.Drug Review. 16. 212-235 (1999)
Hayashi T、Iguchi A.:“NIPRADILOL:具有 NO 释放能力的 β 肾上腺素受体拮抗剂。”Cardiovasc.Drug Review。16. 212-235 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hayashi T.Iguchi A他3名: "Physiological concentration of 17βestnidiel retards the progression of severe athenmelerosis induced by cholesterol diet plus hulloxin injury via NO."Arierioscler Thromb Vase Biol. (印刷中). (2000)
Hayashi T. Iguchi A 和其他 3 人:“17βestnidiel 的生理浓度可延缓由胆固醇饮食和 NO 引起的严重动脉粥样硬化的进展。”Arierioscler Thromb Vase Biol(2000 年出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HAYASHI Toshio其他文献

HAYASHI Toshio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HAYASHI Toshio', 18)}}的其他基金

The regression of atherosclerosis through the regulation of cellular senescence: the possible new therapy for Japanese lifestyle related diseases
通过调节细胞衰老来消退动脉粥样硬化:日本生活方式相关疾病的可能新疗法
  • 批准号:
    24590881
  • 财政年份:
    2012
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of the regression of advanced atherosclerosis through the regulation of cellular senescence-custom-made therapy to Japanese elderly-
通过细胞衰老调节来消退晚期动脉粥样硬化的研究——日本老年人的定制疗法
  • 批准号:
    21590762
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Geriatric and gerontological approach for asian elderly to prevent their atherosclerotic disease and get successful aging.
针对亚洲老年人的老年病学和老年学方法,以预防动脉粥样硬化疾病并实现成功老龄化。
  • 批准号:
    20406004
  • 财政年份:
    2008
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regression of Atherosclerosis by the regulation of nitric oxide and superoxide on vascular endocrinology and vascular aging
通过一氧化氮和超氧化物调节血管内分泌和血管老化来消退动脉粥样硬化
  • 批准号:
    19591043
  • 财政年份:
    2007
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study on Mechanisms of Regional Differences of Side Effects of Hormone Replacement Treatment (HRT)
激素替代治疗(HRT)副作用区域差异机制研究
  • 批准号:
    16406001
  • 财政年份:
    2004
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Gene Therapy of Combined Nitric Oxide Synthases and Related Enzymes to Achieve Complete Regression of Advanced Atherosclerosis-Combined Regulation of Substrate of the Enzymes, Co-factors, Transcriptional Factors and Intracellular Enzymes-
一氧化氮合成酶及相关酶联合基因治疗,实现晚期动脉粥样硬化的彻底消退-酶底物、辅因子、转录因子和细胞内酶的联合调控-
  • 批准号:
    13670704
  • 财政年份:
    2001
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Conformational Analysis of Periodic Polypeptides Containing Pro Residue
含Pro残基的周期性多肽的构象分析
  • 批准号:
    11450373
  • 财政年份:
    1999
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Radiation Effects on Hybrid-Type Medical Materials
放射线对混合型医用材料的影响
  • 批准号:
    08558100
  • 财政年份:
    1996
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Design of Biodegradable Adhesion Prevention
可生物降解的防粘连设计
  • 批准号:
    06453221
  • 财政年份:
    1994
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
  • 批准号:
    2880683
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
  • 批准号:
    23K15842
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
2023 Atherosclerosis
2023 动脉粥样硬化
  • 批准号:
    10675221
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
  • 批准号:
    10570469
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
  • 批准号:
    10585070
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
  • 批准号:
    10619831
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
  • 批准号:
    10974007
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了